Collegium Pharma (COLL) Tops Q2 EPS by 3c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/25/2026

1. DECK
2. RNG
3. WDC
4. BMY
5. BYD
6. WCN
7. SPOT
8. SPY
9. FIX
10. TSCO

Go back to Collegium Pharma (COLL) Tops Q2 EPS by 3c

Collegium Reports Net Income of $8.1 Million in the Second Quarter of 2020

August 5, 2020 4:02 PM EDT

Non-GAAP Net Income of $33.2 Million in the Second Quarter of 2020

Generated $43.9 Million in Cash from Operating Activities in the Second Quarter of 2020

Xtampza ® ER Net Revenue Increased 29% over the Prior Year Period

Conference Call Scheduled for Today at 4:30 p.m. ET

STOUGHTON, Mass., Aug. 05, 2020 (GLOBE NEWSWIRE) --  Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a specialty pharmaceutical company committed to being the leader in responsible pain management, today reported... More